Evidence map›Paper›PMID 18431793›Full record

ArticleCytometry. Part B, Clinical cytometry2008

Standardized method to minimize variability in a functional P2X(7) flow cytometric assay for a multi-center clinical trial.

N L Korpi-Steiner, D Sheerar, E B Puffer, C Urben, J Boyd, A Guadarrama, K Schell, L C Denlinger

Abstract read
In one paragraph

Article in Cytometry. Part B, Clinical cytometry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Protection from asthma in a high-risk birth cohort by attenuated P2X(7) function.The Journal of allergy and clinical immunology · 2012
    Article
  5. Review
  6. Article
  7. Attenuated P2X7 pore function as a risk factor for virus-induced loss of asthma control.American journal of respiratory and critical care medicine · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

N L Korpi-SteinerDepartment of Medicine-Allergy, Pulmonary & Critical Care, University of Wisconsin-Madison, Madison, WI 53792, USA.
D Sheerar
E B Puffer
C Urben
J Boyd
A Guadarrama
K Schell
L C Denlinger
University of Wisconsin–Madison · USUniversity of Wisconsin Carbone Cancer Center · US

Funding

Rhinovirus infection of bronchial epithelium &IL-8 mRNAP01AI050500 · NIAID · UNIVERSITY OF WISCONSIN MADISON · PI GERN, JAMES E. · 2001 to 2005
$5.6M
Treatment of Severe Persistent AsthmaU10HL074212 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI LEMANSKE, ROBERT F · 2003 to 2007
$4.9M
Mentored Clinical Research Scholar Program AwardK12RR017614 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI GRAZIANO, FRANK M · 2003 to 2007
$1.9M
NCRR NIH HHS K12 RR017614NCRR NIH HHS K12 RR01761401NHLBI NIH HHS U10 HL074212NHLBI NIH HHS U10HL074212NIAID NIH HHS P01 AI050500NIAID NIH HHS P01 AI5050001
6 · The paper itself

Abstract

backgroundFlow cytometric analysis of human P2X(7) pore activity segregates variant from common P2RX7 genotypes and may serve as a biomarker for cancer, pain, inflammation, and immune responses to infection. Standardization is needed to accommodate variable sample age and instrumentation differences in a multicenter clinical trial.

methodsCD14-PE-stained whole blood samples were treated with YO-PRO-1 combined with a P2X(7) agonist (BzATP) or control, followed by the addition of PI after closure of the P2X(7) pore. Recalled instrument settings from previous publications were used to adapt a standardized fluorescent particle-adjusted set-up method. Experiments were performed to compare the two methods while evaluating components of systematic variability and facilitating reliable processing of samples with varied ages.

resultsThe median YO-PRO-1 fluorescence of BzATP-treated samples had less variability when collected by the bead-adjusted method and was less influenced by the compensation strategy used. The average day-to-day coefficient of variance for assessments of P2X(7) pore activity by this method was 0.11 +/- 0.04, and the exclusion of nonviable cells was found to accommodate samples aged up to 4 days after phlebotomy. The bead-adjusted set-up method produced measurements differing by only 2.0% +/- 1.5% on two analog cytometers, and within similar decades when comparing analog to digital instruments.

conclusionsThese results provide a standardized method for quantitative flow cytometric analysis of P2X(7) receptor phenotypes in blood monocytes with minimal intralaboratory variation and potential for interlaboratory comparisons that can greatly facilitate multicenter functional genomic clinical studies.

Indexed as

Clinical Trials as TopicMulticenter Studies as TopicAdenosine TriphosphateAgingAsthmaBenzoxazolesCell SurvivalFlow CytometryFluorescenceHumansLipopolysaccharide ReceptorsMonocytesPhlebotomyQuinolinium CompoundsReceptors, Purinergic P2Receptors, Purinergic P2X73'-O-(4-benzoyl)benzoyladenosine 5'-triphosphateAdenosine TriphosphateBenzoxazolesLipopolysaccharide ReceptorsP2RX7 protein, humanQuinolinium CompoundsReceptors, Purinergic P2Receptors, Purinergic P2X7YO-PRO 1

Identifiers

PMID18431793
PMCPMC2622726
OpenAlexW2049110510

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.